The Caris Registry

The Caris Registry™ is a registry of the Target Now® series test results (or biomarker expression patterns) for the evaluation and correlation with clinical outcomes for cancer patients.

The objective of The Caris Registry is to develop an oncology disease research database for the purpose of:

  1. Effecting change in the oncology disease treatment process by advancing precision medicine and improving care for cancer patients through the acquisition and sharing of valuable tumor profiling information of cancerous tumors and clinical outcomes.
  2. Performing retrospective and prospective studies involving analyses of patient medical records, including clinical presentation and outcome as determined by the Target Now® series and The Caris Registry inclusion criteria. The eligible cohort contains select patients having undergone Target Now series evaluation for diagnosis and/or treatment management.
  3. Evaluating the frequency of specific clinical events in relation to risk factors, diagnosis and treatments provided via the collection of outcomes data at 9-month follow-up intervals from the time of patient enrollment through death.
  4. Permitting review of medical record information contained within The Caris Registry – consistent with applicable laws, rules or guidelines on patient privacy, informed consent, data security and human subjects studies – to enable physicians to identify patients who may be eligible for participation in future research studies.

Eligibility:

The Caris Registry is a voluntary registry. There are no pre-defined experimental interventions and limited restrictive exclusion criteria. Prior to enrolling a patient in The Caris Registry, the patient’s physician will have made the independent clinical decision to utilize the Target Now series of molecular profiling tests and made treatment choices as appropriate.

Inclusion criteria:

  • Age greater than or equal to 18 years
  • Diagnosis of cancer
  • Target Now Complete eligible
  • Surgical resection of tumor or tumor biopsy analyzed by Target Now Complete with microarray and IHC analysis and possible FISH or mutational analysis performed.

For more information:

  • To find practices enrolling patients in The Caris Registry, click here.
  • To receive information about the criteria necessary to become a Caris Registry participating entity click here
  • Please watch this page for updates and additional information about The Caris Registry.